LLY
Eli Lilly and Company
NYSE · Healthcare · Drug Manufacturers - General · US
$1,145.09
−1.25%Forward multiples
Based on analyst estimates
- P/E forward
- 28.02x
- P/E 2026E
- 31.47x
- P/E 2027E
- 24.56x
- P/E 2028E
- 21.42x
- P/S forward
- 11.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.36x
- PEG TTM
- 1.04x
- Price / book
- 31.82x
- Price / sales
- 13.53x
- Price / cash flow
- 38.38x
Enterprise value
- Enterprise value
- $1.12T
- EV / sales
- 14.11x
- EV / EBITDA
- 31.92x
- EV / EBIT
- 32.12x
- Market cap
- $1.08T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026